Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wade G. Douglas is active.

Publication


Featured researches published by Wade G. Douglas.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2003

Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy.

Sam M. Wiseman; Thom R. Loree; Nestor R. Rigual; Wesley L. Hicks; Wade G. Douglas; Garth R. Anderson; Daniel L. Stoler

Anaplastic thyroid cancer ranks among the most lethal of all human malignancies. Its rarity and rapidly fatal course have made it a difficult cancer to both study and treat. Unfortunately, there has been little progress in the management and control of this malignancy. Anaplastic transformation, or the intratumoral evolution of anaplastic carcinoma from pre‐existing differentiated thyroid cancer, has become a well‐accepted process, despite a limited understanding of its underlying mechanisms.


Annals of Surgical Oncology | 2003

Squamous Cell Carcinoma of the Head and Neck in Nonsmokers and Nondrinkers: An Analysis of Clinicopathologic Characteristics and Treatment Outcomes

Sam M. Wiseman; Helen Swede; Daniel L. Stoler; Garth R. Anderson; Nestor R. Rigual; Wesley L. Hicks; Wade G. Douglas; Dongfeng Tan; Thom R. Loree

Background: The objective of this study was to describe the clinicopathologic manifestations of disease and outcomes of treatment among individuals without a history of smoking tobacco or consuming alcohol who develop head and neck cancer.Methods: Of 1648 invasive head and neck cancer cases treated between 1970 and 2001 at Roswell Park Cancer Institute, 40 patients were identified as never having smoked tobacco or consumed alcohol during their lifetime. These cases were reviewed to gather data on multiple clinicopathologic variables.Results: Mean age at presentation of nonsmoker/nondrinker head and neck cancer patients was 60 years (range, 27 to 90 years), and 78% (n = 31) of the patients were women. The distributions of tumor sites were 75.0% oral cavity (n = 30), 20.0% oropharynx (n = 8), and 5.0% larynx (n = 2). Sixteen patients (40%) experienced a recurrence of disease during the follow-up period, and 10 patients (25.0%) developed a second primary tumor a median of 6 years after their initial diagnosis.Conclusions: The nonsmoker/nondrinker head and neck cancer patient tends to be elderly and female, have oral cavity primary tumors, and be predisposed to second primary tumor development.


BMC Clinical Pathology | 2005

Tissue eosinophilia: a morphologic marker for assessing stromal invasion in laryngeal squamous neoplasms.

Mahmoud Said; Sam M. Wiseman; Jun Yang; Sadir J. Alrawi; Wade G. Douglas; Richard T. Cheney; Wesley L. Hicks; Nestor R. Rigual; Thom R. Loree; Gregory Spiegel; Dongfeng Tan

BackgroundThe assessment of tumor invasion of underlying benign stroma in neoplastic squamous proliferation of the larynx may pose a diagnostic challenge, particularly in small biopsy specimens that are frequently tangentially sectioned. We studied whether thresholds of an eosinophilic response to laryngeal squamous neoplasms provides an adjunctive histologic criterion for determining the presence of invasion.MethodsEighty-seven(n = 87) cases of invasive squamous cell carcinoma and preinvasive squamous neoplasia were evaluated. In each case, the number of eosinophils per high power field(eosinophils/hpf), and per 10 hpf in the tissue adjacent to the neoplastic epithelium, were counted and tabulated. For statistical purposes, the elevated eosinophils were defined and categorized as: focally and moderately elevated (5–9 eos/hpf), focally and markedly increased(>10/hpf), diffusely and moderately elevated(5–19 eos/10hpf), and diffusely and markedly increased (>20/10hpf).ResultsIn the invasive carcinoma, eosinophil counts were elevated focally and /or diffusely, more frequently seen than in non-invasive neoplastic lesions. The increased eosinophil counts, specifically >10hpf, and >20/10hpf, were all statistically significantly associated with stromal invasion. Greater than 10 eosinophils/hpf and/or >20 eosinophils/10hpf had highest predictive power, with a sensitivity, specificity and positive predictive value of 82%, 93%, 96% and 80%, 100% and 100%, respectively. Virtually, greater than 20 eosinophils/10 hpf was diagnostic for tumor invasion in our series.ConclusionOur study suggests for the first time that the elevated eosinophil count in squamous neoplasia of the larynx is a morphologic feature associated with tumor invasion. When the number of infiltrating eosinophils exceeds 10/hpf and or >20/10 hpf in a laryngeal biopsy with squamous neoplasia, it represents an indicator for the possibility of tumor invasion. Similarly, the presence of eosinophils meeting these thresholds in an excisional specimen should prompt a thorough evaluation for invasiveness, when evidence of invasion is absent, or when invasion is suspected by conventional criteria in the initial sections.


Laryngoscope | 2005

Sentinel Lymph Node Biopsy: A Rational Approach for Staging T2N0 Oral Cancer

Nestor R. Rigual; Wade G. Douglas; Dominick Lamonica; Sam M. Wiseman; Richard T. Cheney; Wesley L. Hicks; Thom R. Loree

Objectives/Hypothesis: For oral cancer patients, the presence of neck nodal metastases is the most important disease prognosticator. However, a significant proportion of clinically N0 patients harbor occult microscopic nodal metastasis. Our objective was to determine the feasibility and accuracy of sentinel node biopsy (SNB) in the staging of T2N0 oral carcinoma patients.


Laryngoscope | 2004

Bronchogenic Cyst Presenting as a Symptomatic Neck Mass in an Adult: Case Report and Review of the Literature

Mazin F. Al‐kasspooles; Ronald A. Alberico; Wade G. Douglas; Alan Litwin; Sam M. Wiseman; Nestor R. Rigual; Thom R. Loree; Wesley L. Hicks

We report the unusual clinical manifestation and subsequent management of a symptomatic congenital bronchogenic cyst that connected to the trachea and presented in the neck of an adult. The embryology, clinical presentation, diagnostic evaluation, and management options of this rare aberration are discussed.


Surgical Oncology Clinics of North America | 2004

Larynx squamous cell carcinoma: concepts and future directions

Pablo Mojica-Manosa; James Reidy; Keith M. Wilson; Wade G. Douglas

The larynx is one of the most important structures in the upper aerodigestive tract. Functional impairment of the larynx is a bur-den to patients who suffer from laryngeal carcinoma, the second most common cancer of the head and neck region after the oral cavity.


Molecular Cancer Research | 2004

Development of Head and Neck Squamous Cell Carcinoma Is Associated With Altered Cytokine Responsiveness

Wade G. Douglas; Erin Tracy; Dongfeng Tan; Jihnhee Yu; Wesley L. Hicks; Nestor R. Rigual; Thom R. Loree; Yanping Wang; Heinz Baumann


Ear, nose, & throat journal | 2004

Parathyroid carcinoma: A multicenter review of clinicopathologic features and treatment outcomes

Sam M. Wiseman; Nestor R. Rigual; Wesley L. Hicks; Saurin R. Popat; John M. Lore; Wade G. Douglas; Michael Jacobson; Dongfeng Tan; Thom R. Loree


Current Opinion in Otolaryngology & Head and Neck Surgery | 2003

Current concepts in the management of a second malignancy of the lung in patients with head and neck cancer.

Wade G. Douglas; Nestor R. Rigual; Thom R. Loree; Sam M. Wiseman; Sadir J. Alrawi; Wesley L. Hicks


Otolaryngology-Head and Neck Surgery | 2005

Advanced soft palate cancer: the clinical importance of the parapharyngeal space.

Wade G. Douglas; Nestor R. Rigual; William Giese; Joseph E. Bauer; Sam M. Wiseman; Thom R. Loree; James K. Schwarz; Sadir J. Alrawi; Wesley L. Hicks

Collaboration


Dive into the Wade G. Douglas's collaboration.

Top Co-Authors

Avatar

Nestor R. Rigual

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Wesley L. Hicks

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Thom R. Loree

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Sam M. Wiseman

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Dongfeng Tan

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Sadir J. Alrawi

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Daniel L. Stoler

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

Garth R. Anderson

Roswell Park Cancer Institute

View shared research outputs
Top Co-Authors

Avatar

James K. Schwarz

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge